In one of the largest randomized controlled trials evaluating the impact of CBT-I on insomnia and inflammation,97 results indicated that CBT-I was associated with a reduced risk of high CRP levels (>3.0 mg/L) at 16 months as compared to both tai chi and a sleep education control. The gene discussed is CRP; the disease is insomnia measurement.